Adjuvant for vaccines comprising a hydrophobic sulfolipid...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 39/39 (2006.01) C08B 37/16 (2006.01)

Patent

CA 2208790

Vaccine adjuvants comprising a sulpholipid polysaccharide in combination with an interface-forming constituent. The invention also provides a method for preparing a vaccine by emulsifying an aqueous solution of an antigen and a sulpholipid polysaccharide. The adjuvants are stable at high temperatures, and are at least as effective as conventional adjuvants. Their local toxicity, i.e. their reactogenicity, is generally lower than that of conventional adjuvants.

Adjuvants pour vaccins comprenant un polysaccharide sulfo-lipidique combiné à un composant formant une interface. On propose également un procédé pour préparer un vaccin en émulsionnant une solution aqueuse d'un antigène et un polysaccharide sulfo-lipidique. Les adjuvants proposés sont stables à haute température, leur efficacité est comparable ou même supérieure à celle des adjuvants classiques. Leur toxicité locale, c'est-à-dire leur réactogénicité est, en général, inférieure à celle des adjuvants classiques.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Adjuvant for vaccines comprising a hydrophobic sulfolipid... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Adjuvant for vaccines comprising a hydrophobic sulfolipid..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Adjuvant for vaccines comprising a hydrophobic sulfolipid... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2028193

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.